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| INTRODUC TI ON
As key organelles widely distributed in most eukaryotic cells, mitochondria are indispensable for diverse cellular processes, from generating adenosine triphosphate (ATP), maintaining calcium homeostasis, synthesizing key metabolites, producing endogenous reactive oxygen species (ROS), to regulating necrosis, apoptosis, and autophagy. [1] [2] [3] Therefore, appropriate regulation of mitochondrial health is of crucial importance to various physiological and patho- , and lead to mitophagy. 4 Mitochondria are removed by the process of autophagy when mammalian reticulocytes mature into erythrocytes. 5 In fertilized Caenorhabditis elegans oocytes, the sperm-derived mitochondria would be removed by mitophagy. 6, 7 These results suggest that maintaining mitochondrial homeostasis by mitophagy plays an important role in the differentiation and development of eukaryotes.
Mitochondrial dysfunction has been implicated in numerous neurodegenerative diseases including Parkinson's disease (PD). PD
is characterized by the degeneration of dopaminergic neurons in the midbrain. Mitochondrial dysregulation can lead to PD. [8] [9] [10] [11] Mutations in PINK1 and Parkin genes are associated with autosomal recessive early-onset PD. 12, 13 PINK1 and Parkin genes exert synergistic effect on mitochondrial maintenance-related functions, such as mitochondrial motility, proteasomal degradation of mitochondrial proteins, and mitophagy. Additionally, Parkin also participates in removing mitochondria during the progression of Alzheimer's disease (AD), and the overexpression of Parkin can alleviate symptoms of AD.
14 Supporting a role of mitophagy in AD, amyloid beta-derived diffusible ligands (ADDLs) can induce the fragmentation of mitochondria and mitophagy. [15] [16] [17] Mitophagy is also altered in HD, and the mutant huntingtin may induce selective autophagy. 18 In a cell culture model of HD, excessive mitochondrial fission partially mediates cytotoxicity. 19 Mitochondrial dysfunction has also been observed in ALS, and reduced targeting of ubiquitinated mitochondria to autophagosomes may contribute to the pathogenesis of ALS. 20 Mitophagy thus plays a multifaced role in neurodegenerative diseases.
| S ELEC TIVE AND NON S ELEC TIVE AUTOPHAGY
Under certain conditions, organelles, together with bits of cytoplasm, will be sequestered and degraded by lysosomes for hydrolytic digestion in a process termed autophagy. 21 Generally, autophagy can be classified into nonselective autophagy and selective autophagy, with the former being primarily a starvation response, while the latter eliminating damaged organelles and remodeling cells to adapt to environmental changes. 22 Defects in selective autophagy can result in a range of human pathophysiologies, including certain types of neurodegenerative diseases. Macroautophagy is an evolutionarily conserved process that allows cells to degrade and recycle cytoplasm. Whereas nonselective macroautophagy can randomly engulf a portion of cytoplasm into autophagosome and subsequently transfer it to the vacuole or lysosome for degradation, selective macroautophagy can specifically identify and degrade specific substances, such as protein complexes, organelles, or invading microorganisms. 23 The morphological hallmark of macroautophagy is the formation of an initial sequestering compartment, the phagophore, which can expand into the double-membrane autophagosome, and the initial sequestration occurs in a compartment separate from the degraded organelle. Typically, selective macroautophagy can be classified into mitophagy, pexophagy, reticulophagy, ribophagy, etc.
In higher eukaryotes, selective autophagy also includes chaperonemediated autophagy (CMA), as well as two similar processes, namely endosomal microautophagy (e-MI) and chaperone-assisted selective autophagy (CASA). 24 Nonetheless, how a substrate is targeted for sequestration and segregated from other cellular parts remains one of the major issues in this research field.
F I G U R E 1 Mechanisms of Mitophagy in mammals. Some OMM proteins, such as BNIP3, NIX, and FUNDC1, possess the LC3-interacting regions (LIRs) and can interact with LC3. Thus, the interaction between the LIRs of mitophagy receptors and LC3 is considered a crucial link in selecting mitochondria as the cargo. Moreover, reversible protein phosphorylation is suggested to effectively regulate the receptor-mediated mitophagy. PINK1 and Parkin synergistically regulate mitophagy in mammals in the same pathway. In the damaged mitochondria, mitochondrial membrane potential is lost and PINK1 accumulates on the membrane. PINK1 would recruit Parkin to the damaged mitochondria and phosphorylate Parkin. Parkin can stimulate the ubiquitination of its substrates on OMM via K48 or K63 linkage, followed by protein quality control and subsequent mitochondrial quality control. was suggested that functional alterations of mitochondria would trigger their autophagy. 30 The term "mitophagy" came into use in 1998. 31 Mitophagy is required to remove the unhealthy mitochondria timely and to maintain steady mitochondrial turnover, as well as cellular development and differentiation. 32 Notably, selective degradation of the surplus or dysfunctional mitochondria by autophagy has been observed in organisms ranging from yeast to mammals. In yeast, mitophagy is mediated by Atg32, which is related to NIX and its regulator Bcl2/adenovirus E1B 19-kDa protein-interacting protein 3 (BNIP3) in mammals. Numerous studies in metazoans suggest that mitophagy is mostly regulated by PINK1 and Parkin, which are not present in yeast, suggesting species-specific difference in mitophagy regulation. Mitophagy is one of the most extensively investigated types of "organelle autophagy," which can be partially ascribed to the connection between mitophagy and disease.
| MITOPHAGY IN MAMMAL S
In mammalian cells, mitophagy is activated by two distinct pathways, one is dependent on receptors while the other one relies on ubiquitin ( Figure 1 ). Although both types of mitophagy, namely the receptormediated and PINK1/Parkin-mediated mitophagy, have been well studied recently, it remains unknown about how these two types of mitophagy differ in expression among different tissues or in output of mitochondrial degradation. 33 In mammals, both NIX (also known as BNIP3L) and SQSTM1/p62 have been implicated to function as the receptors linking mitochondria with the autophagy mechanism in different cell types. During erythrocyte maturation, NIX is essential for mitochondrial clearance, where mitophagy plays a developmental role. Autophagosome can recognize target mitochondria through LC3 adapters (in ubiquitin-dependent and ubiquitin-independent manners) and the direct interaction of LC3 with its receptors. 
| Mitophagy receptors in mammals
The molecular mechanisms of mitophagy in mammals appear to be quite distinct from that in yeast. can not only inhibit the PGAM5 phosphatase activity, but also interact with PGAM5 and block the dephosphorylation of FUNDC1. 46 Under hypoxia condition, ULK1-mediated phosphorylation at Ser17 can promote the interaction between FUNDC1 and LC3. 47 Additionally, the mitochondrial E3 ligase MARCH5 can regulate hypoxia-induced mitophagy through ubiquitinating and degrading FUNDC1. 48 The receptor-interacting serine/threonine-protein kinase 3 (Ripk3) can suppress FUNDC1-mediated mitophagy and promote mitochondrial apoptosis in cardiac ischemia/reperfusion injury. 49 Unexpectedly, it is also suggested that knockdown or overexpression of FUNDC1 has insignificant influence on starvation-or hypoxia-induced mitophagy.
The cause of such divergent results remains to be fully clarified.
In mammalian cells, FUNDC1 can recruit LC3 through its LIR motif, thereby activating mitophagy; it can also interact with DNM1L/DRP1 and OPA1, regulating mitochondrial fission or fusion, and mediating mitophagy. OPA1 can interact with FUNDC1 through its Lys70 (K70) residue, and mutation of K70 to Ala (A) will eliminate the interaction between OPA1 and FUNDC1, and promote mitochondrial fission and mitophagy. 50 Therefore, FUNDC1 can coordinate the dynamics and quality control of mitochondria. PHB2 plays a vital role in the removal of damaged mitochondria. 55, 56 Cardiolipin is a kind of membrane lipid existing in the IMM, which can also serve as a receptor of LC3 in mitophagy. 
| BCL2L13 and FKBP8

| Ambra1
Ambra1, a Beclin 1 interactor, is another mitophagy receptor. After autophagy induction, Ambra1 can gradually transfer from the cytoskeleton to ER and regulate autophagosome nucleation. 60 The PINK1 is also regarded as a mitochondrial stress sensor whose function depends on the mitochondrial membrane potential.
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The PINK1-Parkin pathway may be responsible for regulating the heterogeneity between the healthy and damaged mitochondria and thus mitochondrial homeostasis in cells. Parkin and PINK1 can promote mitochondrial health through several mitochondrial quality control mechanisms, including the turnover of OMM proteins by the proteasome, the generation of mitochondrial-derived vesicles, and organellar degradation through mitophagy. Under healthy mitochondrial condition, PINK1 is maintained at a low level through complex processing and degradation. But PINK1 is stabilized on OMM with decreased mitochondrial membrane potential, where PINK1
can recruit Parkin to damaged mitochondria. 73 Thereafter, PINK1
can phosphorylate Parkin at Ser65 and stimulate Parkin's E3 ligase activity 74 ; PINK1 also phosphorylates ubiquitin at Ser65, which would then activate Parkin upon binding. [75] [76] [77] It is thought that the 
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The mitochondrial fusion GTPase Mfn2 is also a Parkin substrate.
Mfn2 can interact with the Miro-Milton complex on mitochondria
and is therefore also related to the transport of mitochondria. 
| LC3 adapters: p62, NBR1, OPTN, NDP52, and TAX1BP1
The autophagy adaptor proteins, including SQSTM1 (also called p62), NBR1, optineurin (OPTN), NDP52 (also called CALCOCO2), and TAX1BP1, possess the ubiquitin-binding domains, which can interact with the ubiquitinated mitochondrial proteins, and the LIR motifs, which can recruit a separation membrane through interacting with LC3, in the selective autophagic degradation of mitochondria. [86] [87] [88] Among them, OPTN is one of the most studied adapters for the recruitment of phagophore to the mitochondria mediated by the PINK1/Parkin pathway. 89 
| MITOPHAGY AND NEURODEG ENER ATIVE DIS E A S E S
Mitophagy often takes place under baseline conditions; however, it can also be promoted under specific physiological conditions. For example, NIX can remove mitochondria from the mature erythrocytes during development, and Parkin and the mitochondrial E3 ubiquitin protein ligase 1 (MUL1) are necessary for the degradation of paternal mitochondria after fertilization in mice. 96 The differentiation state of stem cells can be affected by the PINK1-dependent mitophagy. 97 On the one hand, mitophagy contributes to metabolic changes during the differentiation and the transition from beige to white adipocytes. 98 On the other hand, mitophagy also exerts great roles in activating the NOD-like receptor protein 3 (NLRP3) inflammasome, and the FUNDC1-dependent mitophagy can downregulate platelet activation following acute ischemia/reperfusion injury. 99, 100 As reviewed below, defective mitophagy is frequently observed in neurodegenerative diseases (Table 1) .
| Mitophagy and PD
Parkinson's disease is characterized by the selective loss of dopa- F-box-containing proteins, sterol regulatory element binding transcription factor 1 (SREBF1), and WD40 domain protein 7 (FBXW7) have been identified as the critical regulators in the PINK/Parkin pathway of mitophagy. 104 Moreover, SREBF1 is also one of the risk factors for sporadic PD, 105 and mitophagy thus may represent a common mechanism linking sporadic and familial PD. [106] [107] [108] Mutation in of the F-box domain is reported to be associated with the early-onset autosomal recessive PD. FBXW7 Parkin is normally a cytosolic protein, which is recruited to dysfunctional mitochondria in a PINK1-dependent manner. 114 Parkin will broadly ubiquitinate and degrade the OMM proteins through the ubiquitin-proteasome system. Our recent studies revealed that on damaged mitochondria, the recruitment of cotranslational quality control factors Pelo, ABCE1, and NOT4 to stalled ribosomes results in NOT4-mediated polyubiquitination of ABCE1 and that polyubiquitinated ABCE1
(poly-Ub-ABCE1) provides a molecular signal for recruiting autophagy receptors to initiate mitophagy. 119 We provided evidence supporting that the PINK1 pathway is deployed to stimulate translation of nuclear-encoded respiratory chain (nRCC) mRNAs on mildly damaged mitochondria to promote RC biogenesis and thus mitochondrial repair, revealing a new physiological role of PINK1/ Parkin in mitochondrial regulation. However, for severely damaged mitochondria that are beyond repair, the PINK1 pathway is used to direct their clearance by mitophagy. Our results also showed that many of the effects of PINK1 in activating mitophagy, from recruit- 
| α-Syn
α-Syn, a natively unfolded protein, is located at the presynaptic terminal of CNS and participates in the vesicular release; however, it can be detected in some abnormally conformational structures, such as amyloid fibril, oligomer, and protofibril. α-Syn is identified as a key constituent of the Lewy bodies, the cytoplasmic inclusions that signify the pathological features of PD. 121, 122 Two autosomal dominant α-Syn gene mutations (namely A53T and A30P) have been associated with PD, 123 In addition to point mutations, some post-translational modifications can also induce the toxic phenotype of protein, including ubiquitination, phosphorylation, oxidation, nitration, and the dopamine-dependent adduct formation. Expression of mutant LRRK2 negatively affects mitochondrial health. Endogenous LRRK2 can interact with the regulators of mitochondrial fission and fusion (such as Drp1, OPA1, and Mfn). 142 In PD patient fibroblasts with LRRK2 G2019S mutation, there is increased susceptibility to MPP + -induced cellular death. 143 The loss of LRRK2 will disrupt the autophagy pathway and promote the production of autophagosomes. 144, 145 Although CMA may mediate the degradation of LRRK2, but the high levels of wild-type LRRK2 will obstruct the translocation of the CMA complex, leading to the deficiency of CMA. 146, 147 The expression of LRRK2 G2019S can stimulate mitophagy, and Recent studies have found that the development of AD is closely correlated with mitochondrial autophagy defects. 153, 154 In a transgenic mouse model of AD, the amyloid-β protein is accumulated, accompanied by a cascade of upregulated mRNA levels of mitochondrial autophagy-associated proteins, such as p62, PARK2, DNM1L, BECN1, BNIP3, PINK1, and LC3. In humans, mice, and even nematodes, Aβ can induce UPR mt and mitophagy in a conserved manner, but the specific mechanism remains to be fully defined. The increases in UPR mt and mitophagy are beneficial, which have been shown to contribute to delaying disease progression and boosting the survival in nematodes. 155 Moreover, Disrupted-in-Schizophrenia-1 (DISC1) has been identified to act as a newly discovered mitophagy receptor. The downregulation of DISC1, as well as Aβ accumulation in AD, will be mutually reinforced, thus creating a vicious circle. Additionally, DISC1 has been shown to protect synapses from Aβ accumulation-associated toxicity through promoting mitophagy. 
| DJ-1
| PINK1/Parkin
The PINK1/Parkin pathway is a hotspot in research concerning the effect of mitophagy on AD pathology. 157, 158 In neurons expressing the human amyloid precursor protein (hAPP), the AD-related mitochondrial stress is found to markedly promote Parkin-dependent mi- 
| Tau
In the case of human wild-type full-length Tau (hTau), its intracellular accumulation will affect the mitochondrial membrane potential, thereby inducing mitochondrial maladjustment and dysfunction.
Besides, it was recently found that hTau can prevent the intracytoplasmic translocation of Parkin to the mitochondrial membrane and inhibit mitophagy in nematode models, while such effect is independent of the changes in membrane potential. On the other hand, the NH2-terminal fragment of tau can regulate Parkin and UCHL-1 through inhibiting the ANT-1-dependent ADP/ATP exchange, suppress mitochondrial autophagy, and mediate synaptic degeneration in AD. 160 
| Sirtuins
There are also other genes and proteins that can act as a bridge between mitophagy and the progression of AD. The sirtuin family is comprised of seven sirtuins. Three of them have been confirmed to be the mitochondrial sirtuins that are closely related to the mitochondrial performance. 161 Resveratrol has been indicated to upregulate SIRT1 expression, thereby protecting neurons from the Aβ aggregation-induced toxicity. It is shown that the antiinflammatory and antioxidant properties of resveratrol can delay the development of AD, and resveratrol can remarkably enhance mitochondrial autophagy. 
| Mitophagy and HD
HD is an autosomal dominant neurodegenerative disease, which is frequently seen in middle-aged people. Its clinical symptoms primarily feature dance-like movements, followed by cognitive impairment, 
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Increasing evidence suggests that mutant Htt can damage mitochondria, leading to energy metabolism disorders, oxidative stress, and release of proapoptotic factors. 18, 169 The aberrant morphology of mitochondria can be observed in the Drosophila model of HD. In addition, mutant Htt is found to cause formation of spherical mitochondria in a nonapoptotic state, and it can also repress mitophagy, resulting in the impaired mitochondrial clearance. 
| GAPDH
Polyglutamine expansion is an important pathogenic mechanism of HD. Recent studies revealed that the amplified polyglutamine can cause mitochondrial dysfunction, which is mainly characterized by morphological abnormalities, blockade of respiratory function, reduced ATP production, and the release of proapoptotic factors.
Such mitochondrial damage is at least partly ascribed to the inactivation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) on mitochondria. This is followed by the inhibition of GAPDH-mediated mitophagy and the accumulation of impaired mitochondria in cells.
GAPDH selectively binds to mitochondria, and overexpression of GAPDH can restore mitochondrial function. Inhibiting the α-tubulin deacetylase HDAC6 is also considered a potential avenue for treating HD, but the mechanism remains unclear,
and studies suggest that HDAC6 may block mitophagy. 174 Various studies have revealed reduced mitophagy in the brain of HD patients, which lead to subsequent dysfunction. 171 Currently, developing treatment strategies for HD by rebuilding stable mitophagy balance has attracted great interests.
| Mitophagy and ALS
ALS is a neurodegenerative disease that develops in adulthood, 
| OPTN/TBK1
Three ubiquitin-LC3-binding autophagy receptors involved in mitophagy have been studied, including OPTN, CALCOCO2, and TAX1BP1. OPTN mutations are well known to underlie the pathogenesis of glaucoma and ALS. 176 It was found that the time course of recruitment of these receptors to the mitochondria is similar, but only OPTN can trigger the subsequent formation of autophagosomes around damaged mitochondria. Moreover, OPTN mutations have been shown in previous studies to enhance NF-κB activity and impede intracellular transport. Besides, mutations are suggested to activate the inflammatory factors, which also contribute to disease progression. 177 As found in recent studies, OPTN will translocate to damaged mitochondria, which is dependent on Parkin ubiquitination of mitochondria. 175 However, this process will be hindered, and mitochondrial accumulation will be impaired if the endogenous OPTN is depleted. Notably, or expression of ALS-associated TBK1 mutants can reduce the mitophagic efficiency of damaged mitochondria. In conclusion, both OPTN and its upstream protein TBK1 are required for normal mitophagy homeostasis. 178 As shown in these studies, TBK1 phosphorylates OPTN, enhancing its ability to bind to ubiquitinated mitochondria, suggesting that TBK1 may also be one of the potential targets for treating ALS. 
| SOD1
SOD1 is one of the most extensively investigated ALS-related genes. Its mutations cause accumulation of hydroxyl radicals, trigger cytotoxicity, and contribute to ALS. Notably, it has recently been reported that SOD1 may indirectly participate in regulating the mitochondrial homeostasis in ALS. 180, 181 On the other hand, it is found that in the SOD1 model of ALS, the flux of mitophagy is decreased. Mitochondria quality control (MQC) can restore mitophagy and reduce the accumulation of impaired mitochondria, which may be ascribed to the potential effect of SOD1 in blocking the reverse transport of autophagosomes in axons. It is suggested that SOD1 relies on Parkin to reduce the rate-limiting factor mitochondrial Rho-GTPase 1 (Miro1), whereas overexpression of Miro1 and inhibition of PINK1 can reverse the autophagosome trafficking defect resulted from the SOD1 mutations. It is suggested that mutant SOD1 would impair axonal transport in a PINK1/Parkin pathway-dependent manner. 182 In the G93A mutant SOD 1 transgenic (SOD1-G93A) mouse model, mitochondria can recruit P62 and activate mitophagy. In that model, the mitochondrial defects are manifested as a variety of protein changes, such as ubiquitin ligase Parkin, mitochondrial biogenesis protein PGC-1α, and Miro1. Knocking down Parkin can reverse such negative effect and improve the pathological symptoms of ALS. But the effect is not sustained and may be compensated by other ubiquitinating enzymes. 169, 183, 184 In addition, VCP also exhibits some properties similar to OPTN;
for instance, it relies on the Parkin-mediated ubiquitination to be recruited to the mitochondria and is involved in mitophagy. The ALSrelated VCP mutations will disrupt the mitophagy balance through the PINK1/Parkin pathway, thereby affecting the clearance of abnormal mitochondria. 185 At present, the pathogenesis of ALS remains to be fully understood, and the existing hypotheses include oxidative stress, mitochondrial dysfunction, excitotoxicity, and neuroinflammation. [186] [187] [188] Notably, research on mitophagy, inflammation, and their interaction has become a hotspot. Improving mitochondrial autophagy and restoring mitochondrial homeostasis may offer potential treatment for ALS.
| CON CLUS IONS
Neurodegenerative diseases are associated with protein turnover, and protein aggregation is involved in the cellular pathology of many neurodegenerative diseases. Mitophagy can partially account for the mechanisms of cellular homeostasis; therefore, appropriate mitophagy level is of great significance to reduce the aggregation of abnormal proteins and to stimulate organelle removal. For the sake of protecting neurons, it is necessary to maintain the mitochondrial function and promote the degradation of damaged mitochondria. The regulation of mitophagy is suggested to be one of the therapeutic strategies for some neurodegenerative diseases.
The activation of mitophagy has been shown to improve neurodegenerative diseases phenotypes and offer neuroprotection. Several therapeutic tools have been confirmed to increase mitophagy, such as the regulators of PINK1/parkin, metformin, and resveratrol. 189 In recent experiments, some drugs are also thought to delay the disease progression, which target the sirtuins family. Sirtuin activating compounds (STACS) or NAD precursors such as NR/NMN can increase mitophagy through regulating sirtuins. 189, 190 Many natural compounds with bioactivation are gradually being discovered.
Some antibiotics or plant ingredients also induce mitophagy, such as actinomycetes. 191 It is associated with mitochondrial autophagy in neural stem cells, which may be mediated by ribosome depletion. 
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